VDAC1 and infection: As a result, the treatment regimens for such infections caused by ESBL producing isolates having porin loss, in BALB/c mice, extend to include colistin in combination with an adjuvant antimicrobial agent such as a carbapenem, rifampicin, or kanamycin (fosfomycin or tigecycline remain for severe infections).